Investors who purchased Primoris Services Corporation shares between August 5, 2025, and June 22, 2026, face a September 21 deadline to join a pending class action lawsuit. The litigation, filed in the Northern District of Texas, alleges the company failed to disclose critical financial risks tied to renewable energy projects.
Allegations of fraudulent billing and unsafe medical practices have triggered a formal investigation into TransMedics Group, Inc. by the law firm Kahn Swick & Foti. The inquiry centers on whether the company’s officers and directors breached their fiduciary duties following a series of damning claims regarding the firm’s organ transplant operations.
Investors who purchased EquipmentShare.com Inc. stock during the company’s January 2026 initial public offering or through June 2026 have until September 21 to join a pending class action lawsuit, according to Kahn Swick & Foti, LLC, the firm representing the plaintiffs in the Southern District of New York.
Investors who purchased AEVEX Corp. common stock between April 17 and June 4, 2026, have until October 20 to petition the U.S. District Court for the Southern District of California for lead plaintiff status in a pending securities fraud lawsuit filed by Kahn Swick & Foti, LLC.
Investors who purchased HDFC Bank securities between July 2023 and May 2026 have until October 13 to join a class action lawsuit in New York. The litigation follows allegations that the bank funneled millions in disguised payments to a state-owned enterprise to secure high-value deposits, triggering a significant stock price drop.
A sharp 18% drop in Procept BioRobotics’ stock price following the disclosure of significant excess field inventory has triggered a securities class action lawsuit. Investors who purchased shares between February 2024 and February 2026 now have until September 22 to file for lead plaintiff status in the California federal court case.
Investors who purchased Capricor Therapeutics securities between December 17, 2025, and July 26, 2026, have until September 28, 2026, to seek lead plaintiff status in a class action lawsuit. The litigation targets alleged failures to disclose material information regarding the company’s lead drug candidate, Deramiocel.
Investors who suffered losses in Simply Good Foods Company stock between October 2024 and April 2026 have until October 13 to seek lead plaintiff status. The class action lawsuit alleges the company concealed critical flaws following its $280 million acquisition of the OWYN brand, triggering a sharp decline in share value.
Investors who purchased Wix.com Ltd. securities between February 19, 2025, and May 12, 2026, have until September 22, 2026, to seek lead plaintiff status in a pending class action lawsuit. The case, filed in the Northern District of Illinois, alleges the company misled shareholders regarding its AI product performance and development costs.
Investors who held Avis Budget Group securities between February 20, 2025, and April 21, 2026, have until September 29, 2026, to join a class action lawsuit. The litigation targets alleged market manipulation involving Pentwater Capital Management, which reportedly leveraged a 51% economic interest to trigger a massive, volatile short squeeze.
Investors who purchased Cogent Communications Holdings shares between February 2024 and May 2026 have until September 21, 2026, to file lead plaintiff applications in a class action lawsuit. The litigation centers on allegations that the company misled shareholders regarding its optical wavelength backlog and underlying financial health.
With an annualized capacity of 107 billion pieces, Zibo-based INTCO Medical has solidified its status as the world’s largest disposable glove manufacturer. The company reported a 40.6% revenue increase to RMB 6.91 billion for the first half of 2026, fueled by a aggressive expansion in production and material supply control.
Investors who purchased Primoris Services Corporation stock between August 5, 2025, and June 22, 2026, face a September 21, 2026, deadline to seek lead plaintiff status in a newly filed securities fraud class action lawsuit currently pending in the Northern District of Texas.
Vancouver-based Inturai Ventures has closed the first tranche of its non-brokered private placement, raising gross proceeds of $940,999.65. The company issued over 6.2 million units priced at $0.15 each to support ongoing research, development, and general working capital as it expands its footprint in the artificial intelligence sector.
Twenty-four attorneys and 11 practices at Greenberg Traurig have secured rankings in the 2027 edition of the Latin Lawyer 250. The guide highlights the firm’s Latin America practice for its ability to leverage its U.S. and Mexico platform to provide cost-efficient, cross-border legal counsel to international clients.
A 66% collapse in EyePoint, Inc. share prices has triggered a formal investigation by Kessler Topaz Meltzer & Check, LLP. The law firm is currently scrutinizing whether the company violated federal securities laws after its lead drug candidate, DURAVYU, failed to meet primary endpoints in a pivotal clinical trial.
After a quarter-century defining South Florida’s Halloween scene, the House of Horror Haunted Carnival is expanding its footprint. Opening September 24 at Tropical Park, the 2026 edition debuts five original haunted attractions, a larger midway, and the nation’s first dark roller coaster designed exclusively for a haunt experience.
Investors who purchased Microvast Holdings, Inc. securities between April 1, 2025, and March 16, 2026, face a September 21, 2026, deadline to apply as lead plaintiff in an ongoing class action lawsuit. The litigation alleges the company misled shareholders regarding its margin targets and facility expansion timelines.
In Montréal, pharmacy executives from across the globe gathered to define the infrastructure required to embed pharmacists into primary health systems. The forum identified four pillars—workforce readiness, sustainable funding, regulatory support, and interprofessional collaboration—as the essential components for scaling clinical roles beyond traditional medication dispensing.
Power Metallic Mines Inc. is launching a series of aggressive marketing and investor relations campaigns to bolster market visibility ahead of its upcoming Mineral Resource Estimate and Preliminary Economic Assessment. The company has finalized multiple service agreements to promote its portfolio, including the flagship Nisk project.
Investors who purchased Insulet Corporation securities between February 21, 2025, and May 26, 2026, have until August 31 to petition the court to serve as lead plaintiff. The litigation follows allegations that the company failed to disclose critical defects in its manufacturing controls and safety procedures.
Tapping into the surge of viral internet animal characters, customization platform iScreen has rolled out an interactive digital pet experience for iOS. The update allows users to place original, expressive companions directly onto their home screens, blending personalized widget aesthetics with the playful energy of current online meme culture.
With over $10 million raised in just two months, the Independent Leadership Council is banking on voter frustration to reshape Congress. Co-founders Heather Manchin, Adam Brandon, and Seth Cohen aim to disrupt the two-party status quo by backing candidates who pledge to govern without caucusing with either Democrats or Republicans.
A San Diego law firm has launched a class action lawsuit against Aardvark Therapeutics, alleging the biopharmaceutical company misled investors about the safety and efficacy of its lead drug candidate, ARD-101. The litigation targets losses incurred by stockholders between the company's February 2025 IPO and mid-May 2026.
Investors who lost more than $100,000 in Photronics, Inc. stock between December 2025 and May 2026 have until September 4 to petition the court to act as lead plaintiff in a pending securities fraud class action. The litigation centers on allegations that the company misled shareholders regarding its product pipeline stability.
Shareholders of the Cohen & Steers Infrastructure Fund received notification regarding the composition of the monthly distribution payable August 31, 2026. The firm disclosed that the entire $0.1650 per share payment for this period is derived from net realized long-term capital gains, continuing the fund's managed distribution policy.
Cohen & Steers Closed-End Opportunity Fund has issued its mandated disclosure regarding the sources of its August distribution, confirming that the $0.0870 per share payout is driven primarily by long-term capital gains. The fund maintains a managed distribution policy designed to provide consistent monthly income to shareholders.
Midvale-based Bamboo Insurance has officially initiated the process to go public, filing a registration statement on Form S-1 with the U.S. Securities and Exchange Commission. The managing general underwriter aims to list its Class A common stock on the New York Stock Exchange under the ticker symbol BMB.
School leaders often rely on generic appreciation weeks to boost morale, but new research suggests these episodic gestures fail to replace substantive, daily recognition. Dr. Contessa Walker-Jackson argues that institutionalizing specific, professional feedback is the only way to ensure teachers feel genuinely valued and supported throughout the academic year.
A federal securities class action has been filed against Flotek Industries following allegations that the energy services firm misled investors regarding a major infrastructure contract. The lawsuit centers on the company’s failure to disclose the cancellation of a $400 million power generation project in Puerto Rico.
